Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry (2020)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1002/clc.23283
- Subjects: INFARTO DO MIOCÁRDIO; DOENÇAS CARDIOVASCULARES; FATORES DE RISCO; INCIDÊNCIA; ANÁLISE DE RISCO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical cardiology
- ISSN: 0160-9289
- Volume/Número/Paginação/Ano: v. 43, n. 1, p. 24-32, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
POCOCK, Stuart J et al. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry. Clinical cardiology, v. 43, n. 1, p. 24-32, 2020Tradução . . Disponível em: https://doi.org/10.1002/clc.23283. Acesso em: 21 fev. 2026. -
APA
Pocock, S. J., Brieger, D., Gregson, J., Chen, J. Y., Cohen, M. G., Goodman, S. G., et al. (2020). Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry. Clinical cardiology, 43( 1), 24-32. doi:10.1002/clc.23283 -
NLM
Pocock SJ, Brieger D, Gregson J, Chen JY, Cohen MG, Goodman SG, Granger CB, Grieve R, Nicolau JC, Simon T. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry [Internet]. Clinical cardiology. 2020 ; 43( 1): 24-32.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1002/clc.23283 -
Vancouver
Pocock SJ, Brieger D, Gregson J, Chen JY, Cohen MG, Goodman SG, Granger CB, Grieve R, Nicolau JC, Simon T. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry [Internet]. Clinical cardiology. 2020 ; 43( 1): 24-32.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1002/clc.23283 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre o DOI: 10.1002/clc.23283 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
